Abstract
Background
Cystogenesis in polycystic kidney disease (PKD) is likely accelerated by various renal insults, including crystal deposition, that activate renal tubule obstruction and dilation. We developed a capsule-based device that can be applied to cystic kidneys to restrict tubular lumen dilatation and cyst expansion.
Methods
Kidney capsule devices were designed from computed tomography images of wild-type and Cy/+ rats. Capsule devices were surgically implanted on kidneys in six surgical sessions over a period of 14 months in 7 wild-type rats of 6.5–8 weeks (3 sham operations, 2 right, 2 left) and 6 Cy/+ rats of 6.5 weeks (2 sham, 3 left, 1 bilateral). After surgery, the rats were followed for 5.4–12.4 weeks’ growth and sacrificed to retrieve the kidneys. During the follow-up, serum creatinine was measured and retrieved kidneys were weighed. Histological analysis including cystic area measurement and immunohistochemistry was performed.
Results
Morphometric capsule devices were configured and developed by an image processing technique and produced using a 3D printer. Encapsulated Cy/+ kidneys (n = 5; mean weight 3.64 g) were consistently smaller in size (by 21–36%; p < 0.001) than unencapsulated Cy/+ kidneys (n = 7; mean weight 5.52 g). Encapsulated Cy/+ kidneys (mean %cyst area: 29.4%) showed smaller histological cystic area (by 28–58%; p < 0.001) than unencapsulated Cy/+ kidneys (mean %cyst area 48.6%). Cell proliferation and macrophages were also markedly reduced in encapsulated Cy/+ kidneys, compared to unencapsulated Cy/+ kidneys.
Conclusions
We report a pilot feasibility study for the application of a novel morphometric 3D capsule device to the Cy/+ rat model showing restricted kidney volume expansion on polycystic kidney disease progression.
References
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G et al (2017) Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med 377:1930–1942
Grantham JJ (2008) Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 359:1477–1485
Kunnen SJ, Malas TB, Semeins CM, Bakker AD, Peters DJM (2018) Comprehensive transcriptome analysis of fluid shear stress altered gene expression in renal epithelial cells. J Cell Physiol 233:3615–3628
Gudipaty SA, Lindblom J, Loftus PD, Redd MJ, Edes K, Davey CF et al (2017) Mechanical stretch triggers rapid epithelial cell division through Piezo1. Nature 543:118–121
Nagao S, Nishii K, Yoshihara D, Kurahashi H, Nagaoka K, Yamashita T et al (2008) Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat. Kidney Int 73:269–277
Brown JH, Bihoreau MT, Hoffmann S, Kranzlin B, Tychinskaya I, Obermuller N et al (2005) Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy/+) rat. J Am Soc Nephrol 16:3517–3526
Mitsouras D, Liacouras P, Imanzadeh A, Giannopoulos AA, Cai T, Kumamaru KK et al (2015) Medical 3D printing for the radiologist. Radiographics 35:1965–1988
Hovater MB, Olteanu D, Hanson EL, Cheng NL, Siroky B, Fintha A et al (2008) Loss of apical monocilia on collecting duct principal cells impairs ATP secretion across the apical cell surface and ATP-dependent and flow-induced calcium signals. Purinergic Signal 4:155–170
Fitz JG (2007) Regulation of cellular ATP release. Trans Am Clin Climatol Assoc 118:199–208
Nagao S, Yamaguchi T, Kusaka M, Maser RL, Takahashi H, Cowley BD et al (2003) Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. Kidney Int 63:427–437
Acknowledgements
We thank Seongho Park, MD (Asan Medical Center, Korea) for support with statistical analysis. This work was supported by grants from the Fujita Health University (PI, S.N.).
Author information
Authors and Affiliations
Contributions
K.T.B., S.H., T.Y., and S.N. formulated the ideas and planned the experiments. K.T.B. designed and developed the 3D kidney capsule devices. K.K. and A.Y. performed the animal experiments. K.K., A.Y., and M.K. analyzed renal function and histology. K.T.B., K.K., A.Y., T.Y., and S.N. analyzed the data and wrote the manuscript. S.H. and J.T.B edited the manuscript. All the authors reviewed and accepted the contents of the article. K.T.B., K.K., and A.Y. equally contributed to this manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
K.T.B. is a consultant to Kadmon, Otsuka, and Sanofi and submitted a provisional patent application. K.K., A.Y., M.K., S.H., T.Y., J.T.B, and S.N. have no conflicts of interest to declare.
Ethical approval
This study was approved by the Fujita Health University Animal Care and Use Committee and followed the ARRIVE guidelines.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bae, K.T., Kumamoto, K., Yoshimura, A. et al. Novel 3D capsule device to restrict kidney volume expansion on polycystic kidney progression: feasibility study in a rat model. J Nephrol 35, 1033–1040 (2022). https://doi.org/10.1007/s40620-021-01160-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-021-01160-5